We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

SLMT:NASDAQBrera Holdings PLC Analysis

Data as of 2026-05-01 - not real-time

$0.76

Latest Price

9/10Risk

Risk Level: High

Executive Summary

SLMT is trading at $0.76, well under its 20‑day (0.81), 50‑day (0.91) and 200‑day (5.63) simple moving averages, signaling a strong bearish bias. The 14‑day RSI sits at 44.5, just below the neutral 50 mark, indicating limited upside momentum. MACD has turned modestly bullish with the line crossing above the signal, but the histogram remains near zero, offering only a faint technical relief. Volume is trending upward, yet the stock’s 30‑day volatility of 119% and a beta exceeding 4 underscore extreme price swings.
Underlying fundamentals are severely distressed: operating margin is –15%, profit margin –1.3%, and cash flow is negative, with a max drawdown of –98%. Debt is massive, with a debt‑to‑equity ratio of nearly 30, dwarfing the modest market cap of $63 million. The price‑to‑book of 0.18 suggests the market values the company at a fraction of its book, but such discount reflects the erosion of equity value. No dividend is paid and earnings per share remain negative, eliminating income‑focused appeal. Recent corporate actions—approval of a name change to Solmate Infrastructure, a reverse split, and the appointment of a new CEO—provide a short‑term catalyst but do not yet resolve the structural financial weaknesses. Moreover, the “Extreme Greed” market sentiment may be inflating price temporarily, while the underlying risk profile remains high.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 7/10

Key Factors

  • price below all major moving averages
  • extreme volatility and high beta
  • recent corporate restructuring creates uncertainty

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • ongoing financial distress with negative cash flow
  • potential upside from restructuring and new leadership
  • still high leverage and weak profitability

Long Term

> 3 years
Cautious
Model confidence: 8/10

Key Factors

  • persistent negative margins and earnings
  • unsustainable debt levels
  • lack of dividend and growth prospects

Key Metrics & Analysis

Financial Health

Revenue Growth-44.40%
Profit Margin-132.49%
ROE-88.21%
ROA-24.92%
Debt/Equity29.77
P/B Ratio0.2
Op. Cash Flow$-4547696
Free Cash Flow$-330547
Industry P/E18.9

Technical Analysis

TrendBearish
RSI44.5
Support$0.66
Resistance$0.99
MA 20$0.81
MA 50$0.91
MA 200$5.63
MACDBullish
VolumeIncreasing
Fear & Greed Index90.98

Valuation

GradeUndervalued
TypeValue

Risk Assessment

Beta4.38
Volatility119.07%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.